期刊文献+

PNL2在皮肤黑素瘤的表达及与预后的相关性

The expression of PNL2 and the correlation with prognosis of melanoma
下载PDF
导出
摘要 目的:检测PNL2在皮肤黑素瘤中的阳性表达率,明确其与预后的关系。方法:采用免疫组织化学SP法检测PNL2在60例皮肤黑素瘤石蜡包埋组织切片中的表达,并分析PNL2在不同年龄、性别、民族、发病部位、淋巴结转移、Clark分级、浸润深度及预后的相关性。结果:PNL2在皮肤黑素瘤中的阳性表达率为90%,与淋巴结转移、Clark分级、浸润深度及预后密切相关(P<0.05),与年龄、性别、民族、发病部位不相关(P>0.05)。结论:PNL2与皮肤黑素瘤的病情发展及预后具有相关性。 Objective: To detect the expression of PNL2 in cutaneous malignant melanoma( MM) and to determine the relationship with the disease progression and prognosis. Methods: The expression of PNL2 in paraffin- embedded tissue samples from 60 cases of MM was detected with immunohistochemistry. The correlation between PNL2 expression and age,gender,ethnicity,pathogenic site,lymph node metastasis,Clark grade,infiltration and prognosis was analyzed. Results: The positivity rate of PNL2 was 90% in melanoma tissue. The PNL2 expression was positively correlated with lymph node metastasis,Clark grade,depth of invasion and prognosis( P〈0. 05),but uncorrelated with age,gender,ethnicity and pathogenic site( P〉0.05). Conclusion: PNL2 is correlated with the disease progression and prognosis in cutaneous MM.
出处 《中国麻风皮肤病杂志》 2015年第12期720-722,共3页 China Journal of Leprosy and Skin Diseases
基金 乌鲁木齐市科学技术计划项目(编号:G131310001) 国家临床重点专科建设项目经费资助
关键词 皮肤黑素瘤 PNL2 侵袭 预后 melanoma PNL2 invasion prognosis
  • 相关文献

参考文献9

  • 1Busam KJ, KucukgN D, Sato E, et al. Immunohistochemical a- nalysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers. Am J Sun Patho|, 2005,29(3) :400-406.
  • 2Nonaka D, Laser J, Tucker R, et al. Immunohistochemica| eval- uation of necrotic malignant melanomas. Am J Clin Pathol, 2007,127(5) :787-791.
  • 3Morris LG, Wen ~H, Nonaka D, et al. PNL2 melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the head and neck. Head Neck, 2008,30 (6) : 771 - 775.
  • 4Ord6fiez NG.Value of melanocytic-associated immunohistochem- ical markers in the diagnosis of malignant melanoma: a review and update. Hum Pathol,2014,45(2) :191-205.
  • 5Rochaix P, Lacroix-Triki M, Lamant L, et al. PNL2, a new monoclonal antibody directed against a fixative-resistant melano- cyte antigen. Mod Pathol,2003,16(5) :481-490.
  • 6Ramos-Vara JA, Frank CB, DuSold D, et al. Immunohisto- chemical expression of melanocytic antigen PNL2, melan A, S100, and PGP 9.5 in Equine Melanocytic Neoplasms. Vet Pathol, 2014,5 l ( 1 ) : 161-166.
  • 7Ramos-Vara ~A, Miller MA. Immunohistochemical identificatio~ of canine melanocytic neoplasms with antibodies to melanocytic antigen PNL2 and tyrosinase: Comparison with melan A. Vet Pathol, 2011,48 (2) : 443-450.
  • 8Aung PP, Sarlomo-Rikala M, Lasota J. KBA62 and PNL2:2 New melanoma markers immunohistochemical analysis of 1563 tumors including metastatic, desmoplastic, and mucosal melano- mas and their mimics. Am J Surg Pathol, 2012,36 ( 2 ) : 265 - 272.
  • 9Giudice C, Ceciliani F, Rondena M. Immunohistochemical in- vestigation of PNL2 reactivity of canine melanocytic neoplasms and comparison with melan a. J Vet Diagn Invest, 2010,22(3) : 389-394.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部